GlassScriptPhysician profile
Nathan De Mcgeathy
NPI 1255786273
$1,966.86
in general payments reported to CMS, 2019-2025
19 companies · $142 in 2025
The $142 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,109 · 2022: $488 · 2023: $106 · 2024: $122 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $369.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $561.14 | 2021-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $239.23 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $216.06 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $211.25 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $145.68 | 2021-2024 | Farxiga |
| Amgen INC. | $114.26 | 2021-2025 | Repatha, Repatha |
| Amarin Pharma, INC. | $112.49 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $111.73 | 2021-2025 | Eliquis |
| Vital Connect, INC | $49.02 | 2024-2025 | Vitalpatch Rtm |
| Mylan Specialty L.P. | $32.83 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.20 | 2021-2022 | |
| Biosense Webster, INC. | $29.14 | 2022 | |
| Abbott Laboratories | $23.87 | 2025 | Cardiomems |
| Glaxosmithkline, LLC. | $19.64 | 2021 | |
| Boston Scientific Corporation | $15.13 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $15.10 | 2021 | |
| Pfizer INC. | $14.69 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.29 | 2023-2024 | Lifevest |
| Medtronic, INC. | $13.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Mcgeathy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.